Vitamin D3 + K2: Do You Need Them Together? Thorne vs Jarrow vs Carlson

2026-10-24 · Author: Vigilant Crow

Our picks

Key takeaways

  • If your vitamin D is low, supplementing fixes it. If it is already normal, big trials found little extra benefit for heart disease, cancer or fractures.
  • Get a blood test (25-hydroxyvitamin D) before you assume you need high doses.
  • K2 (MK-7) has some evidence for slowing bone loss in older women, but the D3+K2 "calcium traffic cop" story is ahead of the data.
  • Anyone on warfarin must not start vitamin K without their doctor.

Vitamin D3 and K2 are sold together so often that it feels like a rule. It is not. This article covers what the big trials actually found, when K2 makes sense, and how three popular brands compare. Living in New England, I care about this one: from roughly October to March the sun is too low to make much vitamin D in your skin.

What the big trials say about vitamin D

The largest U.S. trial, VITAL, gave about 25,000 adults 2,000 IU of vitamin D3 a day or placebo for about five years. It did not lower rates of cancer or major heart events overall (Manson et al., 2019). A follow-up analysis found no reduction in fractures either (LeBoff et al., 2022).

Important detail: most VITAL participants were not deficient to begin with. The Endocrine Society's 2024 guideline now advises against routine vitamin D testing and high doses for healthy adults under 75, while still recommending it for certain groups such as older adults, pregnant people, and people with prediabetes (Demay et al., 2024). Its earlier 2011 guideline, which many supplement sites still quote, focused on treating deficiency (Holick et al., 2011).

In plain terms: vitamin D fixes a deficiency. It is not a booster for people who already have enough. If you rarely get sun, have darker skin, live up north, or are older, you are more likely to be low, and a simple blood test tells you.

Where K2 fits

Vitamin K helps activate proteins that place calcium in bone. The popular pitch is that K2 "directs" the extra calcium absorbed with vitamin D into bones instead of arteries. The mechanism is plausible, but strong human outcome data is thin.

The best-known trial gave 244 healthy postmenopausal women 180 mcg of MK-7 (a form of K2) or placebo for three years. MK-7 slowed age-related bone loss at the spine and hip neck, though not at the total hip (Knapen et al., 2013). The authors noted that it is unclear whether this applies to men or younger adults.

So: K2 is reasonable, low-risk for most people, and has some bone data. It is not proven to prevent heart disease, and you do not need it to take vitamin D safely at normal doses.

MK-7, MK-4 and K1

Vitamin K is not one thing. MK-7, a form of K2, stays in the blood for about three days and has the best bone data at everyday supplement doses: 180 mcg a day slowed bone loss in older women (Knapen et al., 2013). Compared with vitamin K1, MK-7 also produced a more stable, longer-lasting rise in blood vitamin K (Schurgers et al., 2007).

MK-4, the other common K2 form, does not stay in the blood the way MK-7 does. At ordinary supplement doses it was not detectable in serum (Sato et al., 2012). The bone trials that reported a benefit typically used about 45 mg (45,000 mcg) of MK-4 a day, a pharmacologic dose far above typical capsules (Cockayne et al., 2006).

Vitamin K1 (phylloquinone) is the form in leafy greens and is the form the body uses to make clotting proteins (NIH Office of Dietary Supplements).

The warfarin warning

Vitamin K directly counteracts warfarin (Coumadin). Even modest K2 doses can change your INR. If you take warfarin, do not start or stop any vitamin K product without your doctor (NIH Office of Dietary Supplements). Newer blood thinners like apixaban work differently, but still check with your doctor.

How much is safe

Thorne Vitamin D + K2 capsule

One capsule has 5,000 IU of vitamin D3 and 180 mcg of K2 as MK-7, the same MK-7 dose used in the three-year bone trial (Knapen et al., 2013). It is listed as NSF Certified for Sport.

Pros

Cons

Two K2-only options

If you already take vitamin D3 and only want K2, two tested products are worth knowing about. Nature Made Vitamin K2 100 mcg is a plain MK-7 softgel, listed as USP Verified. Nature Made's own store currently marks it discontinued, though the product page is still up. Thorne Vitamin K puts three forms in one capsule: 90 mcg MK-7, 5,000 mcg MK-4 and 1,000 mcg K1. It is listed under NSF/ANSI 173 (contents certified), not NSF Certified for Sport. The MK-4 amount in this capsule is still far below the 45 mg doses used in the older bone trials.

Jarrow Vitamin D3 (with or without MK-7)

Pros

Cons

Carlson Vitamin D3 + K2

Pros

Cons

Who this is not for

Bottom line

Test, don't guess. If your vitamin D is low, a modest D3 dose fixes it, and Jarrow is the cheap, flexible pick. If you want K2 too, choose an MK-7 product like Carlson's combo or Thorne's D + K2 capsule (5,000 IU D3 + 180 mcg MK-7), or a K2-only option such as Nature Made's 100 mcg MK-7 if you already take D3 separately. Skip K2 entirely if you are on warfarin.

Sources

  1. Manson JE, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019. PubMed 30415629 · doi:10.1056/NEJMoa1809944
    In plain English: VITAL: large randomized, placebo-controlled trial of 25,871 US adults 50+ taking 2,000 IU vitamin D3 daily for about 5 years. Did not lower rates of cancer or heart attack/stroke. Limits: participants not selected for low vitamin D.
  2. LeBoff MS, et al. Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med. 2022. PubMed 35939577 · doi:10.1056/NEJMoa2202106
    In plain English: Part of VITAL: 25,871 midlife and older adults, 2,000 IU vitamin D3 daily vs placebo for about 5 years. Vitamin D did not lower fracture risk in people not selected for deficiency or low bone mass. Limits: not about deficient people.
  3. Demay MB, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024. PubMed 38828931 · doi:10.1210/clinem/dgae290
    In plain English: Endocrine Society clinical guideline (2024). For healthy adults under 75, suggests against routine vitamin D testing and high-dose supplements beyond normal recommended intake; suggests supplements for some groups (children, 75+, pregnancy, prediabetes). Limits: based on trials of mostly non-deficient people.
  4. Holick MF, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011. PubMed 21646368 · doi:10.1210/jc.2011-0385
    In plain English: Endocrine Society clinical guideline (2011) on vitamin D deficiency. Recommends testing people at risk and treating deficiency; found not enough evidence to screen everyone. Limits: expert guideline; updated by the 2024 guideline below.
  5. Knapen MH, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013. PubMed 23525894 · doi:10.1007/s00198-013-2325-6
    In plain English: Randomized, double-blind, placebo-controlled trial of 244 healthy postmenopausal women taking 180 mcg/day vitamin K2 (MK-7) for 3 years. MK-7 slowed age-related bone density loss at the spine and hip neck. Limits: only postmenopausal women; may not apply to men or younger people.
  6. Schurgers LJ, et al. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007. PubMed 17158229 · doi:10.1182/blood-2006-08-040709
    In plain English: Human pharmacokinetic study comparing vitamin K1 and MK-7 supplements. Both were absorbed, but MK-7 stayed in the blood much longer (about three days) and built up to more stable levels than K1, which cleared within hours. Limits: absorption and blood-level study, not a bone-outcome trial; also notes MK-7 can interfere with warfarin.
  7. Sato T, Schurgers LJ, Uenishi K. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr J. 2012. PubMed 23140417 · doi:10.1186/1475-2891-11-93
    In plain English: Small study in healthy women comparing 420 mcg single doses, then 60 mcg/day for 7 days, of MK-4 vs MK-7. MK-7 was absorbed and stayed measurable for up to 48 hours; MK-4 was not detectable in serum at these everyday doses. Limits: very small sample; not a bone-outcome trial.
  8. Cockayne S, et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006. PubMed 16801507 · doi:10.1001/archinte.166.12.1256
    In plain English: Systematic review and meta-analysis of vitamin K trials and fractures. The seven trials with fracture data were Japanese and used menaquinone (typically 45 mg/day of MK-4, a pharmacologic dose). The pooled results suggested fewer fractures, but a later journal caution flagged problems in some of those trials, so the fracture benefit is not settled (PubMed 29582044). Limits: mostly high-dose MK-4; included trials later questioned.
  9. NIH Office of Dietary Supplements. Vitamin D fact sheet for health professionals. ods.od.nih.gov
  10. NIH Office of Dietary Supplements. Vitamin K fact sheet for health professionals. ods.od.nih.gov